128 related articles for article (PubMed ID: 1770033)
1. Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy.
Onbe T; Makino H; Kumagai I; Haramoto T; Murakami K; Ota Z
J Diabet Complications; 1991; 5(2-3):167-8. PubMed ID: 1770033
[TBL] [Abstract][Full Text] [Related]
2. Effect of camostat mesilate on urinary protein excretion in three patients with advanced diabetic nephropathy.
Ikeda Y; Ito H; Hashimoto K
J Diabetes Complications; 1999; 13(1):56-8. PubMed ID: 10232711
[TBL] [Abstract][Full Text] [Related]
3. Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.
Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Ishizaki M
J Lab Clin Med; 1990 Aug; 116(2):206-10. PubMed ID: 2394938
[TBL] [Abstract][Full Text] [Related]
4. Effect of camostat mesilate on heavy proteinuria in various nephropathies.
Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Futaki G
Clin Nephrol; 1989 Sep; 32(3):119-23. PubMed ID: 2791362
[TBL] [Abstract][Full Text] [Related]
5. [Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
Onbe T; Makino H; Haramoto T; Wada J; Ogura T; Kumagai I; Murakami K; Fukushima M; Ota Z
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):753-9. PubMed ID: 1770635
[TBL] [Abstract][Full Text] [Related]
6. Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
Matsubara M; Taguma Y; Saito T; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):411-6. PubMed ID: 1635286
[TBL] [Abstract][Full Text] [Related]
7. Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.
Maekawa A; Kakizoe Y; Miyoshi T; Wakida N; Ko T; Shiraishi N; Adachi M; Tomita K; Kitamura K
J Hypertens; 2009 Jan; 27(1):181-9. PubMed ID: 19145783
[TBL] [Abstract][Full Text] [Related]
8. Effect of camostat mesilate on persistent proteinuria of IgA nephropathy.
Matsubara M; Taguma Y; Saito T; Yoshinaga K
Nephron; 1992; 60(2):244-5. PubMed ID: 1553016
[No Abstract] [Full Text] [Related]
9. A proteinase inhibitor reduces proteinuria in nephrotic syndrome.
Makino H; Onbe T; Kumagai I; Murakami K; Ota Z
Am J Nephrol; 1991; 11(2):164-5. PubMed ID: 1951480
[No Abstract] [Full Text] [Related]
10. Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.
Okuno M; Akita K; Moriwaki H; Kawada N; Ikeda K; Kaneda K; Suzuki Y; Kojima S
Gastroenterology; 2001 Jun; 120(7):1784-800. PubMed ID: 11375959
[TBL] [Abstract][Full Text] [Related]
11. Effect of camostat mesilate on puromycin aminonucleoside nephrotic rats.
Suzuki J; Suzuki S; Nozawa R; Kumaki S; Kume K; Higuchi E; Kamiyama S; Ohara N; Yugeta E; Kato K
Fukushima J Med Sci; 1988 Jun; 34(1):21-5. PubMed ID: 3254858
[No Abstract] [Full Text] [Related]
12. Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor.
Senda S; Fujiyama Y; Bamba T; Hosoda S
Intern Med; 1993 Apr; 32(4):350-4. PubMed ID: 8358131
[TBL] [Abstract][Full Text] [Related]
13. Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate.
Takahagi S; Shindo H; Watanabe M; Kameyoshi Y; Hide M
Acta Derm Venereol; 2010 Jul; 90(4):425-6. PubMed ID: 20574618
[No Abstract] [Full Text] [Related]
14. An inhibition of urinary albumin excretion by protease inhibitor in streptozotocin-diabetic rats.
Ikeda T; Hoshino T
Nephron; 1996; 74(4):709-12. PubMed ID: 8956306
[TBL] [Abstract][Full Text] [Related]
15. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A
Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371
[TBL] [Abstract][Full Text] [Related]
16. Hepatic and pancreatic metabolism and biliary excretion of the protease inhibitor camostat mesilate.
Beckh K; Weidenbach H; Weidenbach F; Müller R; Adler G
Int J Pancreatol; 1991; 10(3-4):197-205. PubMed ID: 1787334
[TBL] [Abstract][Full Text] [Related]
17. Glomerular deposition of alpha 2-macroglobulin in a child with steroid refractory nephrotic syndrome.
Asami T; Ohsawa S; Tomisawa S; Hashimoto K; Toyabe S; Sakai K
Nephron; 1992; 61(2):211-3. PubMed ID: 1378560
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effect of camostat mesilate (FOY 305) on acute experimental allergic encephalomyelitis (EAE).
Inuzuka T; Sato S; Baba H; Miyatake T
Neurochem Res; 1988 Mar; 13(3):225-8. PubMed ID: 2455235
[TBL] [Abstract][Full Text] [Related]
19. In vivo effects of camostat mesilate on plasma kallikrein, plasma kininase II and renal kallikrein of man.
Bönner G; Babst H; Kaufmann W
Arzneimittelforschung; 1987 May; 37(5):535-7. PubMed ID: 3040018
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
Ashizawa N; Hashimoto T; Miyake T; Shizuku T; Imaoka T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Apr; 21(4):767-71. PubMed ID: 16677167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
